* Lucira Health Inc LHDX.OQ reported a quarterly adjusted loss
of 38 cents per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 32 cents per share.
* Revenue was $12.44 million; analysts expected $8.00
million.
* Lucira Health Inc's reported EPS for the quarter was a loss
of 42 cents.
* The mean earnings estimate of analysts had risen by about 2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Lucira Health Inc shares had risen by 20.9% this quarter.
* The company reported a quarterly loss of $16.2 million.
* Wall Street's median 12-month price target for Lucira Health
Inc is $8.50
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
This summary was machine generated August 12 at 09:02 p.m. All
figures in US dollars unless otherwise stated